Showing results (251-260 of 1,132) with videos related to
Sort By:
Pageof 114
Journal of Hepatocellular Carcinoma|May 27, 2021
Phase I Trial on Arterial Embolization with Hypoxia Activated Tirapazamine for Unresectable Hepatocellular CarcinomaNadine Abi-Jaoudeh, Farshid Dayyani, Pei Jer Chen, et al.Journal of Hepatocellular Carcinoma|December 26, 2022
Advanced Hepatocellular Carcinoma in Adults Without Cirrhosis: A Single-Institution Retrospective ReviewEllery Altshuler, Raymond Richhart, Mahmoud Aryan, et al.Journal of Hepatocellular Carcinoma|June 21, 2021
Rates of Hepatocellular Carcinoma After Start of Treatment for Chronic Hepatitis C Remain High with Direct Acting Antivirals: Analysis from a Swiss Liver Transplant CenterFatih Karbeyaz, Seraphina Kissling, Paul Julius Jaklin, et al.Journal of Hepatocellular Carcinoma|June 24, 2021
Current Understanding of Ablative Radiation Therapy in Hepatocellular CarcinomaAshwathy S Mathew, Laura A DawsonJournal of Hepatocellular Carcinoma|June 24, 2021
Effectiveness of Transarterial Chemoembolization-First Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching AnalysisSung Won Chung, Min Kyung Park, Young Youn Cho, et al.Journal of Hepatocellular Carcinoma|December 16, 2022
Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical ResearchFrancesca Fornari, Catia Giovannini, Fabio Piscaglia, et al.Journal of Hepatocellular Carcinoma|December 27, 2022
ARFIP2 Regulates EMT and Autophagy in Hepatocellular Carcinoma in Part Through the PI3K/Akt Signalling PathwayKaida Huang, Yubiao Lin, Keyin Wang, et al.Journal of Hepatocellular Carcinoma|June 9, 2022
Trial Designs for Integrating Novel Therapeutics into the Management of Intermediate-Stage Hepatocellular CarcinomaYung-Yeh Su, Yi-Sheng Liu, Chin-Fu Hsiao, et al.Journal of Hepatocellular Carcinoma|December 7, 2022
Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular CarcinomaJin-Tao Huang, Bin-Yan Zhong, Nan Jiang, et al.Journal of Hepatocellular Carcinoma|July 12, 2022
Understanding the Role of Metabolic Syndrome as a Risk Factor for Hepatocellular CarcinomaNorberto C Chavez-Tapia, Sofía Murúa-Beltrán Gall, Ana Luisa Ordoñez-Vázquez, et al.Pageof 114